Browsing Tag
Bridgewater
2 posts
Insmed (NASDAQ: INSM) rebounds as retail eyes ATS 2026 readouts after Q1 reset
INSM bounced 11% after a 20% post-earnings reset. BRINSUPRI is launching faster than any respiratory drug in a decade. So why did the market sell the print?
Can OmniActive’s Capsimax carve out a natural GLP-1 niche in the fast-changing weight wellness market?
OmniActive says new Capsimax data supports natural GLP-1 activity, metabolism, and exercise performance. Read what the study could mean now.